325
Views
13
CrossRef citations to date
0
Altmetric
Reviews

Effects of Coffee, Black Tea and Green Tea Consumption on the Risk of Non-Hodgkin’s Lymphoma: A Systematic Review and Dose–Response Meta-Analysis of Observational Studies

, , ORCID Icon &
Pages 887-897 | Received 20 Nov 2018, Accepted 05 Feb 2019, Published online: 02 May 2019
 

Abstract

Aim: Several studies have evaluated the association between coffee, black and green tea consumption and non-Hodgkin’s lymphoma (NHL) risk, while the results were inconsistent. We conducted a dose–response meta-analysis of available observational studies to assess the association among coffee, black and green tea intake and the risk of NHL in the general population.

Methods: Studies published up to August 2018 were identified on the basis of a literature search in PubMed, ISI Web of Science, Scopus and Cochrane databases using Mesh and non-Mesh relevant keywords. Relative risks (RRs) with 95% confidence intervals (CIs) and the dose–response relationships were calculated using random-effects models.

Results: In the meta-analysis of 19 effect sizes (315,972 participants with 4,914 cases of NHL), we found that higher green tea intake was associated with a 39% reduced risk of NHL (pooled RR = 0.61; 95% CIs = 0.38–0.99, I2=60.4%, pheterogeneity=0.080) in high- versus low-intake meta-analysis. No association was observed between coffee intake (pooled RR = 1.21; 95% CIs = 0.97–1.50, I2=52.6%, pheterogeneity  <  0.05), black tea intake (pooled RR = 1.01; 95% CI = 0.82–1.24, I2=0%, pheterogeneity=0.875) and risk of NHL in high- versus low-intake meta-analysis.

Conclusions: Findings from this dose–response meta-analysis suggest that green tea intake may be associated with reduced risk of NHL.

Disclosure Statement

The authors declare that there is no conflict of interest.

Additional information

Funding

This work was supported by the Students' Scientific Research Center, Tehran University of Medical Sciences and Health Services, Tehran, Iran, under Grant number 97-03-61-39263.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.